This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Sertraline Versus Venlafaxine XR in Major Depressive Disorder

Ana Lusicic, MD, and Karuppiah Jagadheesan, MD, FRANZCP

Published: October 15, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: A recent study by Shelton et al.1 suggests that sertraline and venlafaxine XR have a comparable efficacy in treating major depressive disorder. The following comments would enable an improved understanding of this study. Shelton et al.1 stated that participants were outpatients but did not clarify what process was involved in such recruitment.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...